Low-dose metformin and PEN2-dependent lysosomal AMPK activation: benefits outnumber side effects

Signal Transduct Target Ther. 2022 Jun 4;7(1):178. doi: 10.1038/s41392-022-01040-9.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • AMP-Activated Protein Kinases / genetics
  • Lysosomes
  • Metformin* / pharmacology

Substances

  • Metformin
  • AMP-Activated Protein Kinases